Cite
Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.
MLA
Iijima, Yuki, et al. “Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.” Clinical Lung Cancer, vol. 19, no. 6, Nov. 2018, pp. e843–47. EBSCOhost, https://doi.org/10.1016/j.cllc.2018.07.002.
APA
Iijima, Y., Hirotsu, Y., Mochizuki, H., Amemiya, K., Oyama, T., Uchida, Y., Kobayashi, Y., Tsutsui, T., Kakizaki, Y., Miyashita, Y., & Omata, M. (2018). Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer. Clinical Lung Cancer, 19(6), e843–e847. https://doi.org/10.1016/j.cllc.2018.07.002
Chicago
Iijima, Yuki, Yosuke Hirotsu, Hitoshi Mochizuki, Kenji Amemiya, Toshio Oyama, Yoshinori Uchida, Yoichi Kobayashi, et al. 2018. “Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.” Clinical Lung Cancer 19 (6): e843–47. doi:10.1016/j.cllc.2018.07.002.